Keyphrases
Alzheimer's Disease
100%
Chronic Low Back Pain (cLBP)
51%
Osteopathy
44%
Acute Lymphoblastic Leukemia
39%
Texas
38%
Mexican Americans
38%
Functional Restoration
34%
Chronic Pain
33%
Mild Cognitive Impairment
28%
United States
28%
Osteopathic
27%
Non-Hispanic White
23%
Confidence Interval
23%
Older Adults
22%
Tuberculosis
22%
Low Back Pain
22%
Childhood Acute Lymphoblastic Leukemia
20%
High Risk
20%
Wrist
19%
Heart Rate
19%
Risk Factors
18%
Aging Brain
17%
Pain Management
17%
Tolfenamic Acid
17%
Spinal Disorders
16%
Dementia
16%
Clinical Trials
16%
Cocaine
15%
Disability
15%
Temporomandibular Disorders
14%
Blood Biomarkers
14%
Low Back Pain Patients
14%
Cognitive Impairment
14%
Biopsychosocial Approach
14%
Treatment Outcome
13%
Breast Cancer
13%
Treatment Group
12%
Down Syndrome
12%
Primary Care
12%
Pentylenetetrazole
11%
Randomized Controlled Trial
11%
Pain-related Disability
11%
Cognitively Normal
11%
Health Disparities
10%
Range of Motion
10%
Hispanic
10%
Osteopathic Physicians
10%
Single nucleotide Polymorphism
10%
Healthcare
10%
Specificity Protein 1
10%
Neurofilament Light (NF-L)
10%
Healthcare Professionals
10%
Return to Work
10%
Minimal Residual Disease
10%
Executive Function
9%
Chronic Disabling Occupational musculoskeletal Disorders
9%
Socioeconomic Outcomes
9%
Mycobacterium Tuberculosis (M. tb)
9%
Cardiopulmonary Bypass
9%
Alzheimer's Disease Biomarkers
9%
Clinical Outcomes
9%
Psychopathology
9%
Pain Intensity
8%
Discriminative Stimulus
8%
Diazepam
8%
Hispanic Americans
8%
African American
8%
Opioids
8%
Chronic Pain Patients
8%
Methotrexate
8%
Type 2 Diabetes Mellitus (T2DM)
8%
Cognitive Decline
8%
Biofeedback
8%
Ligament
8%
Scaphoid
8%
Pain Patients
8%
Medical Students
8%
Early Intervention
8%
Healthcare Utilization
8%
Treatment Programs
7%
Adults with Down Syndrome
7%
Multi-ethnic
7%
Transcription Factor
7%
Mean Arterial Pressure
7%
Proteomics
7%
Group Studies
7%
Brain Studies
7%
Flexion
7%
Retrospective Cohort Study
7%
Neuropsychological Tests
7%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
7%
Placebo
7%
Cardiovascular Risk
7%
Blood-based
7%
Total tau
6%
Alzheimer's Disease Risk
6%
Clinical Utility
6%
Acute Myeloid Leukemia
6%
Capitate
6%
Complete Remission
6%
Medicine and Dentistry
Low Back Pain
38%
Disease
38%
Acute Lymphoblastic Leukemia
33%
Alzheimer's Disease
31%
Manual Therapy
25%
Biological Marker
23%
Primary Health Care
22%
Injury
21%
Chronic Pain
20%
Rehabilitation Engineering
19%
Health Care Cost
18%
Prevalence
16%
Drug Therapy
15%
Osteopathic Medicine
14%
Health Care
13%
Symptom
13%
Opiate
12%
Musculoskeletal Disease
12%
Clinical Trial
11%
Malignant Neoplasm
11%
Diagnosis
11%
Spinal Disorder
11%
Randomized Controlled Trial
9%
Pediatrics
9%
Anatomy
9%
Quality of Life
9%
Minimal Residual Disease
9%
Cadaver
9%
Cardiopulmonary Bypass
9%
Cognitive Defect
9%
Pyruvic Acid
9%
Medical Care
8%
Human Immunodeficiency Virus
8%
Surgery
7%
Cross Sectional Study
7%
Analgesia
7%
Methotrexate
7%
Musculoskeletal Pain
7%
Thermal Burn
7%
Amyloid
7%
Tuberculosis
7%
Retrospective Cohort Study
7%
Clinician
6%
Systematic Review
6%
Group Therapy
6%
Medicine
6%
Diabetes
6%
Mild Cognitive Impairment
6%
Body Mass Index
6%
Computer Assisted Tomography
6%
Health Disparity
6%
Down Syndrome
6%
Personalized Medicine
5%
Oncology
5%
COVID-19
5%
Placebo
5%
Tau
5%
Infection
5%
Maturity Onset Diabetes of the Young
5%
Adolescent
5%
Leukemia
5%
Extracorporeal Membrane Oxygenation
5%
Acute Myeloid Leukemia
5%
Family Practice
5%
Spine Surgery
5%
Logistic Regression Analysis
5%
Mental Health
5%
Lumbar Spine
5%
Leukocyte
5%
Carpal Bone
5%
Emergency Department
5%
Geriatrics
5%
Medical Student
5%
Occupation (Patient Social Context)
5%
Breast Cancer
5%
Childhood Cancer
5%
Neoplasm
5%